GlassScriptPhysician profile
Jorge A Martinez
NPI 1992748883
$24,389.33
in general payments reported to CMS, 2019-2025
78 companies · $4,152 in 2025
The $4,152 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,973 · 2020: $2,810 · 2021: $3,703 · 2022: $2,554 · 2023: $3,054 · 2024: $4,143 · 2025: $4,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,135.53 |
| Education | $213.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,685.92 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $2,008.72 | 2019-2025 | Evenity, Otezla, Repatha |
| Abbvie INC. | $1,948.86 | 2020-2025 | |
| Glaxosmithkline, LLC. | $1,632.13 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $1,273.61 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,259.49 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,212.19 | 2019-2025 | Jardiance, Tradjenta |
| Janssen Pharmaceuticals, INC | $1,190.01 | 2019-2024 | Xarelto |
| Pfizer INC. | $967.15 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $809.80 | 2019-2025 | |
| Corcept Therapeutics | $695.13 | 2019-2025 | Korlym |
| Merck Sharp & Dohme LLC | $611.13 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Otsuka America Pharmaceutical, INC. | $545.50 | 2022-2025 | Rexulti, Nuedexta |
| Bayer Healthcare Pharmaceuticals INC. | $505.15 | 2021-2025 | |
| Esperion Therapeutics, INC. | $467.28 | 2020-2025 | Nexletol |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $412.70 | 2019-2025 | Prolastin-C Liquid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $365.51 | 2019-2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $359.53 | 2019-2023 | |
| Astellas Pharma US INC | $352.22 | 2019-2024 | Veozah |
| Allergan, INC. | $351.10 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $294.43 | 2024-2025 | Ingrezza |
| Radius Health, INC. | $262.47 | 2020-2025 | |
| Horizon Therapeutics Plc | $235.48 | 2019-2021 | |
| Abbott Laboratories | $227.22 | 2019-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $195.12 | 2021-2025 | Recorlev, Gvoke Hypopen, Keveyis |
| Mannkind Corporation | $186.41 | 2019-2023 | Afrezza |
| Regeneron Healthcare Solutions, INC. | $184.09 | 2019-2023 | Dupixent |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $169.88 | 2025 | Caplyta |
| Eisai INC. | $166.35 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $161.57 | 2025 | Austedo Xr |
| Antares Pharma, INC. | $152.61 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Amarin Pharma, INC. | $129.80 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $128.56 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $127.93 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $119.87 | 2023-2025 | Gemtesa |
| Dexcom, INC. | $119.17 | 2019-2025 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $107.31 | 2019-2024 | Yupelri |
| Lundbeck LLC | $106.35 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $100.16 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Shire North American Group INC | $91.94 | 2019 | |
| Biogen, INC. | $90.53 | 2024-2025 | Leqembi |
| Pharming Healthcare, INC. | $84.16 | 2022 | |
| Abiomed | $69.21 | 2025 | |
| Arbor Pharmaceuticals, INC. | $62.53 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $62.45 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Ultragenyx Pharmaceutical INC. | $60.23 | 2020-2023 | Crysvita |
| Vanda Pharmaceuticals INC. | $56.13 | 2020-2025 | Fanapt |
| Recordati_rare_diseases_inc. | $55.88 | 2025 | Isturisa |
| Travere Therapeutics, INC. | $51.55 | 2023-2024 | |
| Insulet Corporation | $50.59 | 2023 | Omnipod |
| Nevro Corp. | $50.36 | 2019 | |
| Hologic Sales and Service, LLC | $49.49 | 2021-2022 | |
| Medtronic, INC. | $48.94 | 2025 | Symplicity G3 |
| Boston Scientific Corporation | $48.22 | 2022-2024 | Watchman Flx |
| Si-Bone, INC. | $46.53 | 2022-2023 | |
| Alkermes, INC. | $45.63 | 2025 | Aristada, Lybalvi |
| Phathom Pharmaceuticals, INC. | $44.23 | 2024-2025 | Voquezna |
| Cequr Corporation | $40.53 | 2024 | Cequr Simplicity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.43 | 2019 | |
| Avanir Pharmaceuticals, INC. | $38.35 | 2019-2021 | |
| Mdd US Operations, LLC | $37.22 | 2024 | Gocovri |
| Inspire Medical Systems, INC. | $29.06 | 2025 | Inspire |
| Edwards Lifesciences Corporation | $26.13 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ironwood Pharmaceuticals, INC | $25.37 | 2024 | |
| Csl Behring | $24.26 | 2024 | Haegarda |
| Verona Pharma, INC. | $23.66 | 2025 | Ohtuvayre |
| Biosense Webster, INC. | $21.94 | 2021 | |
| Tms Neurohealth Centers INC. | $20.91 | 2025 | Tms Neurohealth Centers INC. |
| Azurity Pharmaceuticals, INC. | $20.87 | 2023 | Edarbi |
| Neotract INC. | $20.29 | 2019 | |
| Vertos Medical, INC. | $17.61 | 2024 | Mild Device Kit |
| Daiichi Sankyo INC. | $17.26 | 2020 | |
| Tactile Systems Technology INC | $16.60 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.17 | 2022 | |
| Intra-Sana Laboratories | $15.00 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Sunovion Pharmaceuticals INC. | $14.99 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.44 | 2023 | Quviviq |
| Medline Industries LP | $13.73 | 2023 |
Drugs and devices associated with these payments
Vraylar $925Jardiance $747Airsupra $636Verquvo $601Leqvio $536Rexulti $474Breztri $470Otezla $462Farxiga $409Repatha $401Prolastin-C Liquid $375Tradjenta $334Kerendia $299Ingrezza $294Mounjaro $294Evenity $294Nexletol $270Xifaxan $263Ozempic $257Rybelsus $240Entresto $233Zepbound $219Arexvy $203Abrysvo $199Aristada $183Leqembi $175Prolia $172Caplyta $170Trelegy Ellipta $149Lokelma $135Freestyle Libre 3 $134Gemtesa $120Wegovy $114Prevnar 20 $105Comirnaty $105Nuedexta $103Belsomra $88.82Qulipta $83.50Yupelri $83.10Cologuard Collection Kit $83.07Austedo Xr $82.07Emgality $78.20Korlym $76.63Veozah $76.01Dexcom G6 Transmitter $75.05Steglatro $72.30Recorlev $71.99Ubrelvy $69.13Gvoke Hypopen $61.41Enbrel $60.57Kisunla $59.96Zavzpret $56.58Nurtec Odt $56.58Isturisa $55.88Omnipod $50.59Symplicity G3 $48.94Shingrix $48.53Xarelto $46.83Lybalvi $45.63Voquezna $44.23Cequr Simplicity $40.53Afrezza $38.99Dupixent $38.48Gocovri $37.22Linzess $36.69Nocdurna $34.67Tlando $34.67Xyosted $34.67Fanapt $34.56Watchman Flx $30.28Keveyis $30.02Inspire $29.06Lagevrio $28.27Edwards Sapien 3 Transcatheter Heart Valve (Thv) $26.13Haegarda $24.26Ohtuvayre $23.66Tms Neurohealth Centers INC. $20.91Edarbi $20.87Crysvita $20.80Zoryve $20.25Mild Device Kit $17.61The Cologuard Plus Collection Kit $17.09Seglentis $15.86Livalo $15.86Glycate $15.00Reltone 200 Mg $15.00Reltone 400 Mg $15.00Quviviq $14.44Soliqua 100/33 $13.74Creon $11.32Paxlovid $6.38
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.